One more program to confuse us when needing a prescription, although I’m sure there is money to be saved here, but shoot I like the $4.00 or $10.00 generic prescriptions offered by others, no enrollment and no questions asked, simple. For the monthly fee, you might need to be a patient with some...
Posted to
The Medical Quack .... by Barbara Duck
on 11-06-2008
Filed under: Medically Related, Insurance, Pharma/FDA News, Other Items of Interest, drugs, healthcare, health insurance, Prescriptions, Medicare Part D, Aetna, Pharmacy, Costco
I will once more mention a potential change of paradigms here with educating the public. Each patient who took the drug is unique. Do we have any information on other drugs they were taking at the same time? Groups will continue to advise against the use until the full facts are known...
Posted to
The Medical Quack .... by Barbara Duck
on 10-31-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, healthcare, Pharma, PHR, FDA, Marketing, paradigms, personal heatlh records
Even folks with money and in high positions have problems getting access to cancer drugs, as you can read below, and this was not an issue of not being able to afford the medication. When you read items as such, it makes you stop and think how precious life and healthcare really is. BD ...
Posted to
The Medical Quack .... by Barbara Duck
on 10-31-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, Cancer, Tysabri, Access to medications, Cancer Drugs, Fred Baron, Biogen
New program to educate pharmacists on pharmacogenomics. The efforts are going forward to help the pharmacists also explain to the patients how it works and what the information has to offer. The new group of graduates will be the first group of pharmacists to be information equipped. ...
Posted to
The Medical Quack .... by Barbara Duck
on 10-24-2008
Filed under: Medically Related, Technology, Other Items of Interest, Genomics, drugs, Pharmacy, DNA Testing, Phamaceuticals, Pharmacogonomics, healthare
Investors and analysts using The Healthcare Exchange will be able to ask questions of physicians, such as their opinions about a new treatment or device. Sermo has been a community website restricted to physicians to compare and collaborate within their peers and now with the new service investors...
Posted to
The Medical Quack .... by Barbara Duck
on 10-23-2008
Filed under: Medically Related, Technology, Other Items of Interest, drugs, healthcare, Investors, Physicians, Prescriptions, clinical trials, Sermo, Bloomberg, MCconnect, opinions
I wonder if all the name brand companies will one day have nothing but generics? (grin). There’s always this interesting topic too, biosimilars. “Because biosimilars aren't exact duplicates of the original drugs, they don't violate the original drug's patent , enabling legal distribution...
Posted to
The Medical Quack .... by Barbara Duck
on 10-16-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, Pharma, Generic Drugs, Marketing, Pfizer, Biosimilars
Whistle blower case where Pharma Sales representative created an investigation and settlement. Whistle blowers can and do receive portions of settlements, and in this case there was $46 million. The uses marketed by Cephalon were not approved by the FDA. Doctors can prescribe...
Posted to
The Medical Quack .... by Barbara Duck
on 09-29-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, Pharma, Marketing, Whistle Blower, Off Label Drug use, Cephalon